Kenya vs Netherlands: Pneumococcal conjugate second or third-dose vaccines (PCVc) immunizati
Kenya
87.0%
in 2025
Netherlands
87.0%
in 2025
Kenya rank
86th
Netherlands rank
86th
Pneumococcal conjugate second or third-dose vaccines (PCVc) immunizati over time
- Kenya
- Netherlands
How they compare
Kenya currently reports 87.0% against 87.0% in Netherlands, a difference of 0.0%.
The two have swapped places 2 times across 18 shared years of data; in 2008 it was Netherlands ahead.
Kenya ranks 86th and Netherlands ranks 86th of 194 countries.
Across the 3 decades both report, Kenya averaged higher in 1 and Netherlands in 2.
Head to head by decade
| Decade | Kenya | Netherlands | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 0.0% | 48.0% | 48.0% | Netherlands |
| 2010s | 75.1% | 94.6% | 19.5% | Netherlands |
| 2020s | 91.0% | 89.8% | 1.2% | Kenya |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher pneumococcal conjugate second or third-dose vaccines (pcvc) immunizati, Kenya or Netherlands?
- Kenya, at 87.0% against 87.0% in Netherlands as of 2025.
- What is the difference in pneumococcal conjugate second or third-dose vaccines (pcvc) immunizati between Kenya and Netherlands?
- 0.0%, with Kenya ahead.
- How many years of comparable data are there for Kenya and Netherlands?
- 18 years are reported by both, from 2008 to 2025.
- How do Kenya and Netherlands rank globally for pneumococcal conjugate second or third-dose vaccines (pcvc) immunizati?
- Kenya ranks 86th and Netherlands ranks 86th of 194 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Pneumococcal conjugate second or third-dose vaccines (PCVc) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid refreshes it automatically from the source and publishes the full history for both places.